Xtant Medical Holdings Profit Margin 2010-2018 | XTNT
Current and historical gross margin, operating margin and net profit margin for Xtant Medical Holdings (XTNT) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Xtant Medical Holdings net profit margin as of September 30, 2018 is -57.08%.
|Xtant Medical Holdings Annual Profit Margins
|Xtant Medical Holdings Quarterly Profit Margins
||Medical Instruments Manufacturing
Xtant Medical Holdings, Inc. develops, manufactures and markets biologics products. The Company's product used in an applications which includes enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries. Xtant Medical Holdings, Inc., formerly known as Bacterin International Holdings, Inc., is based in Belgrade, United States.